What is Myhep 400mg (1X28) (SOFOSBUVIR / VELPATASVIR)?
Pangenotypic HCV treatment — all genotypes 1–6. Single daily tablet for 12 weeks achieves over 97% cure rates in most patient populations.
How it Works
Sofosbuvir (NS5B polymerase inhibitor) blocks viral RNA synthesis; velpatasvir (NS5A inhibitor) blocks viral replication complex assembly. Pan-genotypic dual mechanism.
Quick Specs
| Form | Oral tablets — pre-dosed |
| Shelf Life | 2–3 years (properly stored) |
| Storage | Room temperature (15–25°C), cool dry place |
| Brand | Pharma |
| Pack Size | 112 tablets |
| Dose per Tablet | 400MG |
Frequently Asked Questions
🧪 Peptide Research Tools: Use QSC's free peptide calculators — reconstitution, BAC water, dosing, half-life, and mixing charts.
🌍 Domestic shipping: 🇺🇸 USA 5–7 days
🌏 International shipping: 7–14 days